Next Generation News and Research

RSS

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.

16 Nov 2009

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

M3 USA, together with Bristol-Myers Squibb, is launching a pilot program to oncologists using M3’s next-generation eLearning and eMarketing solution. The solution – M3 Messages™ – takes a new approach to developing valuable, long-term, online connections that help doctors stay current on advances in oncology.

13 Nov 2009

CNS Pharmaceuticals' common shares sponsored by 886 AG on the electronic trading platform Xetra

CNS PHARMACEUTICALS AG, (C35.F) a developer and marketer of patented natural nutraceutical products is pleased to announce that the Company’s common shares is sponsored by the German Securities Trading Bank 886 AG Wertpapier Handelsbank on the electronic trading platform Xetra.

13 Nov 2009

New science of happiness doing a profound disservice

The new sciences of happiness are generating lots of advice on how to keep smiling. The results are even being explored by policy wonks. So why does so much of it - work less, say thanks, keep fit - sound so trite? If it were that easy, wouldn't we all be happy by now? The reason is that a central and tricky question is being glossed over: just what is happiness? Moreover, how you try to promote happiness depends entirely on what you take happiness to be - and there's a wealth of choice in that.

13 Nov 2009

SpinalMotion submits Kineflex lumbar artificial disc PMA to FDA

SpinalMotion, developer of the investigational Kineflex® lumbar and Kineflex/C® cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has submitted the Pre-Market Approval (PMA) to FDA for the Kineflex lumbar artificial disc

13 Nov 2009

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

Mithridion, Inc., a biopharmaceutical company focusing on developing drugs for serious Central Nervous System (CNS) disorders, announced today progress with its pipeline of potential oral small-molecule drugs for Alzheimer's disease (AD) and schizophrenia.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

K2M announces the launch of TERRA NOVA and SERENGETI

K2M, Inc., the spinal device company developing innovative and simplified solutions for the treatment of complex spinal pathologies and procedures, today announced the launch of the TERRA NOVA® Minimally Invasive Access System and the SERENGETI® Disposable Kit at the North American Spine Society (NASS) 2009 Annual Conference.

12 Nov 2009

Nicast to launch the NovaMesh intra-abdominal hernia mesh in Europe

Nicast, developer of medical devices made of electrospun nanofabric, announced today it is readying to launch the NovaMesh intra-abdominal hernia mesh in the European market in Q1 2010, pending European regulatory approval. NovaMesh is the first intra-abdominal hernia mesh to utilize the special properties of electrospun nanofabric.

12 Nov 2009

IMS Health to launch comprehensive analytical tool for oncology market

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company’s clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.

12 Nov 2009

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Ocutec Ltd, the medical devices specialist today announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene )glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses.

11 Nov 2009

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States

11 Nov 2009

OmSanA: A new option to maintain healthy blood sugar and cholesterol levels

The holidays should be a time when Americans focus on celebrating, reuniting with loved ones, enjoying holiday feasts and seemingly endless holiday treats. But, for the roughly 127 million Americans that struggle with maintaining healthy blood sugar and cholesterol levels, the stress of nearly two months of festivities can place enormous pressure on a body’s ability to maintain normal blood sugar and cholesterol levels.

11 Nov 2009

First evidence-based, multidisciplinary treatment guidelines for brain metastases patients to be published

Anthony Asher, MD, FACS, of Carolina Neurosurgery & Spine Associates in Charlotte, NC, has co-authored the first evidence-based, multidisciplinary treatment guidelines for brain metastases patients. These guidelines were recently presented at the Congress of Neurological Surgeons 2009 Annual Meeting in New Orleans, and were developed over the last year by a 20-member panel from various medical specialties.

11 Nov 2009

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge.

11 Nov 2009

First draft of the cassava genome complete

A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of research on this subsistence crop and addressing some of the many limitations that face cassava farmers around the world.

11 Nov 2009

Sanofi-aventis, Regeneron sign agreement to expand development collaboration

Sanofi-aventis and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.

11 Nov 2009

Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting

Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma.

11 Nov 2009

IntriCon to launch new CDM device at 2009 AHA Scientific Sessions

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, announced today that it will unveil a prototype of its new Cardiac Diagnostic Monitoring (CDM) device, called the Mobile Patient ECG Telemetry System, or MPETS, at the 2009 American Heart Association (AHA) Scientific Sessions, Nov. 15-17, in Orlando, Fla.

11 Nov 2009

GORE TAG Thoracic Endoprosthesis receives European CE Mark approval

W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.

11 Nov 2009

Next Generation News and Research

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

CNS Pharmaceuticals' common shares sponsored by 886 AG on the electronic trading platform Xetra

New science of happiness doing a profound disservice

SpinalMotion submits Kineflex lumbar artificial disc PMA to FDA

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

K2M announces the launch of TERRA NOVA and SERENGETI

Nicast to launch the NovaMesh intra-abdominal hernia mesh in Europe

IMS Health to launch comprehensive analytical tool for oncology market

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

OmSanA: A new option to maintain healthy blood sugar and cholesterol levels

First evidence-based, multidisciplinary treatment guidelines for brain metastases patients to be published

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

First draft of the cassava genome complete

Sanofi-aventis, Regeneron sign agreement to expand development collaboration

Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting

IntriCon to launch new CDM device at 2009 AHA Scientific Sessions

GORE TAG Thoracic Endoprosthesis receives European CE Mark approval

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News